UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

SP0059 Inflammatory Myositis in the 21St Century: Clinical Care and Management

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.16-16

Chinoy, H.

2014

Link zum Volltext

Verfügbarkeit prüfen

Phenotype Standardization for Statin-Induced Myotoxicity

Clinical pharmacology and therapeutics, 2014-10, Vol.96 (4), p.470-476

2014

Link zum Volltext

Verfügbarkeit prüfen

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases

Rheumatology (Oxford, England), 2014-02, Vol.53 (2), p.213-222

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Annals of the rheumatic diseases, 2009-10, Vol.68 (10), p.1621-1625

2009

Link zum Volltext

Verfügbarkeit prüfen

Interaction of HLA-DRB103 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.961-965

2012

Link zum Volltext

Verfügbarkeit prüfen

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

Annals of the rheumatic diseases, 2007-10, Vol.66 (10), p.1345-1349

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of protein aggregation in the pathogenesis of inclusion body myositis

Clinical and experimental rheumatology, 2022-02, Vol.40 (2), p.414

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

Rheumatology (Oxford, England), 2008-03, Vol.47 (3), p.324-328

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)

British journal of dermatology (1951), 2013-04, Vol.168 (4), p.802-807

2013

Link zum Volltext

Verfügbarkeit prüfen

Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey

Rheumatology international, 2023-10, Vol.43 (10), p.1925-1934

2023

Link zum Volltext

Verfügbarkeit prüfen

GATM gene variants and statin myopathy risk

Nature (London), 2014-09, Vol.513 (7518), p.E1-E1

2014

Link zum Volltext

Verfügbarkeit prüfen

The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures

Journal of the European Academy of Dermatology and Venereology, 2016-01, Vol.30 (1), p.86-91

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis

Journal of the European Academy of Dermatology and Venereology, 2018-09, Vol.32 (9), p.1530-1534

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum muscle damage markers in the idiopathic inflammatory myopathies: quantifying disease activity and identifying cardiac involvement

Neuromuscular disorders : NMD, 2017-03, Vol.27, p.S39-S40

2017

Link zum Volltext

Verfügbarkeit prüfen

OP0057 Idiopathic Inflammatory Myopathy is Associated with an Increased Risk of Cardiovascular Events in the First Five Years After Diagnosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.89-89

2015

Link zum Volltext

Verfügbarkeit prüfen

Time for a 'joint' approach?

British journal of dermatology (1951), 2013-04, Vol.168 (4), p.683-684

2013

Link zum Volltext

Verfügbarkeit prüfen

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies

Annals of the rheumatic diseases, 2014-09, Vol.73 (9), p.1750-1752

2014

Link zum Volltext

Verfügbarkeit prüfen

THU0411 Secukinumab Efficacy in Anti-TNF-Naive and Anti-TNF-IR Patients with Psoriatic Arthritis: Results of a Phase 3 Multicenter, Double-Blind, Placebo-Controlled Study (Future 2)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.345-346

2015

Link zum Volltext

Verfügbarkeit prüfen

OP0279 The Standardised Mortality Rate in UK Adult-Onset Myositis Patients is Seven Times Higher than the UK General Population

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.177

2015

Link zum Volltext

Verfügbarkeit prüfen

AB0629 Design of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of The Toll-like Receptor Antagonist IMO-8400 in Patients with Dermatomyositis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1119-1119

2016

Link zum Volltext

Verfügbarkeit prüfen

11. A comparative study of the clinical features of dermatomyositis in child and in adult patients where the Anti-Mi-2 antibody is present

Rheumatology (Oxford, England), 2017-12, Vol.56 (suppl_7)

2017

Link zum Volltext

Verfügbarkeit prüfen

Defining cancer risk in dermatomyositis. Part I

Clinical and experimental dermatology, 2009-06, Vol.34 (4), p.451-455

2009

Link zum Volltext

Verfügbarkeit prüfen

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis–scleroderma overlap

Rheumatology (Oxford, England), 2007-12, Vol.46 (12), p.1786-1791

2007

Link zum Volltext

Verfügbarkeit prüfen

The Group Theatre: Passion, Politics, and Performance in the Depression Era

1, 2013

Link zum Volltext

Verfügbarkeit prüfen

Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology

Clinical and experimental dermatology, 2009-07, Vol.34 (5), p.561-565

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(199)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

SP0059 Inflammatory Myositis in the 21St Century: Clinical Care and Management

Phenotype Standardization for Statin-Induced Myotoxicity

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Interaction of HLA-DRB103 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

The role of protein aggregation in the pathogenesis of inclusion body myositis

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)

Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey

GATM gene variants and statin myopathy risk

The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures

Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis

Serum muscle damage markers in the idiopathic inflammatory myopathies: quantifying disease activity and identifying cardiac involvement

OP0057 Idiopathic Inflammatory Myopathy is Associated with an Increased Risk of Cardiovascular Events in the First Five Years After Diagnosis

Time for a 'joint' approach?

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies

THU0411 Secukinumab Efficacy in Anti-TNF-Naive and Anti-TNF-IR Patients with Psoriatic Arthritis: Results of a Phase 3 Multicenter, Double-Blind, Placebo-Controlled Study (Future 2)

OP0279 The Standardised Mortality Rate in UK Adult-Onset Myositis Patients is Seven Times Higher than the UK General Population

AB0629 Design of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of The Toll-like Receptor Antagonist IMO-8400 in Patients with Dermatomyositis

11. A comparative study of the clinical features of dermatomyositis in child and in adult patients where the Anti-Mi-2 antibody is present

Defining cancer risk in dermatomyositis. Part I

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis–scleroderma overlap

The Group Theatre: Passion, Politics, and Performance in the Depression Era

Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology

Suchergebnisse filtern